OncoDaily Partners with World Radiotherapy Awareness Day to Champion Access, Awareness and Better Cancer Care

By Aren Karapetyan, MD Sep 6, 2026

Fact checked by Susanna Mikayelyan, MD

Medically reviewed by Amalya Sargsyan, MD

We are proud to announce a new partnership between OncoDaily and World Radiotherapy Awareness Day (WRAD).

Together, we will work to strengthen global awareness of the essential role of radiotherapy in cancer care, highlight the importance of equitable access, and amplify the voices of professionals and organizations advancing radiotherapy worldwide.

Radiotherapy is a cornerstone of cancer treatment, yet access and awareness remain unequal across many parts of the world. Through this partnership, we aim to bring greater visibility to these challenges, share progress from across the radiotherapy community, and support a stronger global conversation around access, awareness, and equity.

We look forward to supporting World Radiotherapy Awareness Day and working together to help ensure that the importance of radiotherapy is recognized worldwide.

Read more about WRAD on their official website!

Author

Aren Karapetyan

Aren Karapetyan is a practicing radiation oncologist at Erebuni Radiotherapy Center and an active media professional serving as a content creator and editor-in-chief for OncoDaily RT. His clinical work focuses on specialized radiotherapy for head and neck as well as genitourinary cancers also he evaluates new research as a peer reviewer.

Fact checked by Susanna Mikayelyan MD Susanna Mikayelyan, MD, is a hematology resident physician at the Yeolyan Hematology and Oncology Center and a medical writer with the OncoDaily Intelligence Unit. Her medical education began at Yerevan State Basic Medical College, where an interest in chemistry and pharmacology led her to study pharmacy from 2016 to 2019. During her final year, she was awarded a nominal scholarship and graduated with honors. She subsequently entered the Faculty of General Medicine at Yerevan State Medical University. While studying medicine, a growing interest in disease and therapeutic mechanisms led her to pursue a subspecialty deeply grounded in pathophysiology and pharmacology. She graduated from Yerevan State Medical University with honors in 2025 and, later that year, entered residency training in hematology, with a particular clinical interest in hematologic oncology. Since April 2026, Susanna has been a medical writer with the OncoDaily Intelligence Unit. Her work focuses on hematologic malignancies, spanning disease biology, emerging research, clinical trials, and scientific meetings, synthesizing complex evidence into clear, clinically relevant content for physicians, researchers, and the wider oncology community. Outside medicine, she enjoys art history, cinematography, football, motorsports, and learning foreign languages through literature and self-study.

Medically reviewed by Amalya Sargsyan MD Amalya Sargsyan, MD, MSc, is a medical oncologist in Yerevan, Armenia, and Vice President of Research & Intelligence at OncoDaily. She heads the Sarcoma Service at D'Clinic, treats adult solid tumors at the Adult Solid Tumors and Chemotherapy Clinic of the Yeolyan Hematology and Oncology Center, and leads the Adult Solid Tumor Team at the Immune Oncology Research Institute. Her clinical practice covers sarcoma, gastrointestinal cancers, and adolescent and young adult (AYA) oncology. She earned her MD and completed medical oncology residency at Yerevan State Medical University, then an MSc in Precision Medicine in Clinical Practice at the University of Cyprus. Her sarcoma training began at the Bank of Cyprus Oncology Centre and continued through a three-month fellowship at the Sarcoma Unit of Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, organized with the European School of Oncology, followed by observerships at Memorial Sloan Kettering Cancer Center and the sarcoma program at Stanford Medicine. She trained in gastrointestinal oncology under the mentorship of Yelena Janjigian at MSK, as a recipient of the ASCO Conquer Cancer International Development and Education Award and Memorial Sloan Kettering GI Oncology International Training Award. Her research addresses access and equity in cancer care in low- and middle-income countries. She is principal investigator of the IMMONKG study, a multinational retrospective cohort examining alternative immune checkpoint inhibitor dosing strategies across LMICs, and first author of the JCO Global Oncology analysis of immunotherapy access in Armenia's out-of-pocket health system (Sargsyan et al., 2025). She has authored and contributed to peer-reviewed publications in journals including Nature Reviews Clinical Oncology, JCO Global Oncology, The Lancet Oncology, and Expert Review of Gastroenterology & Hepatology. She has received ESMO Leadership and Career Development Award in 2026, the ESMO Merit Award twice and the ASCO Conquer Cancer International Development and Education Award. At OncoDaily she directs the Research & Intelligence unit, overseeing global oncology content strategy, editorial operations across six disease verticals, and more than 50 scientific events a year - including the How I Treat virtual summit series. She is an Adjunct Assistant Professor at Yerevan State Medical University, founder of the Young Oncology Group of Armenia, and founder of the ASCO Oncology Student Interest Group at Yeolyan.